CL2008000980A1 - Forma cristalina anhidra de docetaxel; metodo de preparacion, util como antitumoral. - Google Patents

Forma cristalina anhidra de docetaxel; metodo de preparacion, util como antitumoral.

Info

Publication number
CL2008000980A1
CL2008000980A1 CL200800980A CL2008000980A CL2008000980A1 CL 2008000980 A1 CL2008000980 A1 CL 2008000980A1 CL 200800980 A CL200800980 A CL 200800980A CL 2008000980 A CL2008000980 A CL 2008000980A CL 2008000980 A1 CL2008000980 A1 CL 2008000980A1
Authority
CL
Chile
Prior art keywords
anhydra
antitumoral
docetaxel
useful
preparation
Prior art date
Application number
CL200800980A
Other languages
English (en)
Inventor
Kim Namdu
Seob Shin Woo
Jung Jaehyuk
Jeong Kim Gi
Hwan Oho Seung
Jung Lim; Eun
Moon; Youngho
Chang Young-Kil
Lee Sun Gwan
Original Assignee
Hanmi Pharm Ind Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hanmi Pharm Ind Co Ltd filed Critical Hanmi Pharm Ind Co Ltd
Publication of CL2008000980A1 publication Critical patent/CL2008000980A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
CL200800980A 2007-04-10 2008-04-04 Forma cristalina anhidra de docetaxel; metodo de preparacion, util como antitumoral. CL2008000980A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020070035065A KR100878455B1 (ko) 2007-04-10 2007-04-10 안정한 무수결정형 도세탁셀 및 이의 제조방법

Publications (1)

Publication Number Publication Date
CL2008000980A1 true CL2008000980A1 (es) 2008-08-22

Family

ID=39831157

Family Applications (1)

Application Number Title Priority Date Filing Date
CL200800980A CL2008000980A1 (es) 2007-04-10 2008-04-04 Forma cristalina anhidra de docetaxel; metodo de preparacion, util como antitumoral.

Country Status (10)

Country Link
US (1) US20100099897A1 (es)
EP (1) EP2155709A4 (es)
JP (1) JP2010523647A (es)
KR (1) KR100878455B1 (es)
CN (1) CN101652356A (es)
AR (1) AR065928A1 (es)
CL (1) CL2008000980A1 (es)
PE (1) PE20090045A1 (es)
TW (1) TW200906813A (es)
WO (1) WO2008123751A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006130978A1 (en) 2005-06-06 2006-12-14 The University Of British Columbia Polymer-based serum albumin substitute
KR101149600B1 (ko) * 2009-12-31 2012-05-29 주식회사 삼양제넥스바이오 고순도 무수결정형 도세탁셀 제조방법
CA2791416C (en) 2010-03-01 2018-05-15 The University Of British Columbia Derivatized hyperbranched polyglycerols
EP2566474B1 (en) 2010-05-03 2017-11-15 Teikoku Pharma USA, Inc. Non-aqueous taxane pro-emulsion formulations and methods of making and using the same
US8842114B1 (en) 2011-04-29 2014-09-23 Nvidia Corporation System, method, and computer program product for adjusting a depth of displayed objects within a region of a display
JO3685B1 (ar) 2012-10-01 2020-08-27 Teikoku Pharma Usa Inc صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها
US10500285B2 (en) 2015-05-15 2019-12-10 Zhuhai Beihai Biotech Co., Ltd. Docetaxel and human serum albumin complexes
WO2018081520A1 (en) 2016-10-27 2018-05-03 Zhuhai Beihai Biotech Co., Ltd. Neutral ph compositions of docetaxel and human serum albumin

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2722191B1 (fr) 1994-07-08 1996-08-23 Rhone Poulenc Rorer Sa Procede de preparation du trihydrate du (2r,3s)-3-tertbutoxycarbonylamino-2-hydroxy-3-phenylpropionate de 4-acetoxy2alpha-benzoyloxy-5beta,20epoxy-1,7beta,10beta trihydroxy-9-oxo-tax-11-en-13alpha-yle
US7176325B2 (en) * 2002-04-05 2007-02-13 Natural Pharmaceuticals, Inc. Selective acylation of secondary hydroxyl groups
US6838569B2 (en) * 2002-12-16 2005-01-04 Dabur India Limited Process for preparation of paclitaxel trihydrate and docetaxel trihydrate
US7838551B2 (en) * 2003-12-12 2010-11-23 Quiral Quimica do Basil S.A. Process for the preparation of concentrated, sterile injectable solutions containing docetaxel
FR2864340B1 (fr) * 2003-12-19 2006-03-24 Commissariat Energie Atomique Microcomposant comportant une microcavite hermetique et procede de fabrication d'un tel microcomposant
CN100420681C (zh) 2005-04-29 2008-09-24 上海奥锐特国际贸易有限公司 多烯紫杉醇三水物的制备方法
WO2007044950A2 (en) * 2005-10-12 2007-04-19 Sicor, Inc. Crystalline forms of docetaxel and processes for their preparation
KR100995390B1 (ko) * 2006-01-02 2010-11-19 주식회사 삼양제넥스 무정형, 무수결정형 또는 수화 결정형 도세탁셀의 제조방법
BRPI0600194A (pt) * 2006-01-30 2007-10-23 Quiral Quimica Do Brasil S A composições farmacêuticas contendo docetaxel e um inibidor de degradação e processo de obtenção das mesmas
EP2094084A4 (en) * 2006-10-20 2010-01-13 Scinopharm Singapore Pte Ltd PROCESS FOR PREPARING CRYSTALLINE WATER-FREE DOCETAXEL

Also Published As

Publication number Publication date
KR20080091945A (ko) 2008-10-15
CN101652356A (zh) 2010-02-17
AR065928A1 (es) 2009-07-08
PE20090045A1 (es) 2009-03-22
US20100099897A1 (en) 2010-04-22
EP2155709A1 (en) 2010-02-24
KR100878455B1 (ko) 2009-01-13
WO2008123751A1 (en) 2008-10-16
TW200906813A (en) 2009-02-16
EP2155709A4 (en) 2010-09-15
JP2010523647A (ja) 2010-07-15

Similar Documents

Publication Publication Date Title
NO2021006I1 (no) Quofenix, delafloksacin
BRPI0814466A2 (pt) Método.
BRPI1011414A8 (pt) "método."
BRPI1011965A2 (pt) estrutura de entressola.
FR2929502B1 (fr) Implant nucleique.
BRPI0922208A2 (pt) método de mineração de minerio.
BRPI1007047A2 (pt) Biorrefino irganosolv de cana-de-açúcar inteira.
CU24152B1 (es) 1,2 oxazol-8-azabiciclo[3,2,1]octano 8 il como moduladores de fxr
FR2962442B1 (fr) Composition stable de 2,3,3,3-tetrafluoropropene
BRPI1008939A2 (pt) 2-mercaptoquinolina-3-carboxamidas substituídas como moduladores de kncq2/3.
BRPI1010301A2 (pt) composição.
UY33125A (es) Diaza-espiro-[5,5]-undecanos
BRPI0924664A2 (pt) eletrodo ,e ,método para construir um eletrodo.
BRPI0919898A2 (pt) 4,5,6,7-tetra-hidrotienopiridinas substituídas como moduladores de kcnq2/3
ATE527260T1 (de) (dihydro)pyrroloä2,1-aüisoquinoline
CL2008000980A1 (es) Forma cristalina anhidra de docetaxel; metodo de preparacion, util como antitumoral.
BR112012003151A2 (pt) composição de revestimento, e, método.
IT1396487B1 (it) Convogliatore.
BRPI1009519A2 (pt) 3-amino-2-mercaptoquinolina substituída como modulador de kcnq2/3.
BRPI1011014A2 (pt) método de produção.
BRPI1014932A2 (pt) método de compactação de material.
FR2944149B1 (fr) Electrode composite.
BRPI1015429A2 (pt) máquina de embalagem, e, método de embalagem.
IT1401713B1 (it) Supporto intervertebrale.
IT1396642B1 (it) Statore.